本页面由Tiger Trade Technology Pte. Ltd.提供服务

Altimmune, Inc.

2.56
-0.0500-1.92%
盘后:2.580.0197+0.77%19:59 EDT
成交量:215.97万
成交额:557.66万
市值:4.97亿
市盈率:-3.37
高:2.63
开:2.59
低:2.56
收:2.61
52周最高:6.44
52周最低:2.55
股本:1.94亿
流通股本:1.64亿
量比:0.49
换手率:1.32%
股息:- -
股息率:- -
每股收益(TTM):-0.7600
每股收益(LYR):-0.9999
净资产收益率:-28.87%
总资产收益率:-17.20%
市净率:1.05
市盈率(LYR):-2.56

数据加载中...

2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/12/20

重要事件披露

8-K - Current report
2022/11/10

重要事件披露

8-K - Current report
2022/11/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/09/29

重要事件披露

8-K - Current report
2022/09/14

重要事件披露

8-K - Current report
2022/08/11

重要事件披露

8-K - Current report
2022/08/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/07/07

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/05/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/12

重要事件披露

8-K - Current report
2022/03/24

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/03/15

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/15

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/15

重要事件披露

8-K - Current report
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals